Tag: Lycotec
Reduction of effective dose of statins, by liver targeting delivery, could be a way to bring the drugs to the prevention market – proof-of-concept trial by Lycotec Ltd.
Cambridge UK (PRWEB UK) 23 June 2015 Statins are one of the most successful drugs able to slow down the formation of cholesterol-rich atherosclerotic plaques on the arterial walls, and reduce the development of and mortality from coronary heart disease, CHD. Although their efficacy in management of elevated LDL cholesterol and […]